Company
Investment-firm
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
founded date
founders
Company Type
IPO status
Contacts
Similar Companies528
TVM Capital Healthcare
TVM Capital Healthcare is a private equity firm focused on healthcare investments.
Sector
Subsector
Keywords
Location
total rounds
count Of Investments
count Of Exists
Blue Ox Healthcare Partners
Blue Ox Healthcare Partners is a private equity investment firm that invests in growth-stage healthcare companies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Varsity Healthcare Partners
Varsity Healthcare Partners is a private equity firm that invests in healthcare provider platforms.
Sector
Subsector
Location
total rounds
total raised
count Of Investments
Oresund Healthcare Management
Øresund-Healthcare Capital is a venture capital firm that invests in healthcare companies.
Sector
Subsector
Keywords
Location
count Of Investments
Financials
Investments18
Moon Surgical
Moon Surgical is a medical device company that aims to augment surgeons with computer vision, haptics, and robotics.
Sector
Subsector
Location
total rounds
total raised
Autobahn Therapeutics
Autobahn Therapeutics develops CNS therapies using human biology and brain-targeting chemistry.
Sector
Subsector
Keywords
Location
total rounds
total raised
Moon Surgical
Moon Surgical is a medical device company that aims to augment surgeons with computer vision, haptics, and robotics.
Sector
Subsector
Location
total rounds
total raised
Co-Investors
People
Founders1
Alan Au
Alan is a veteran in healthcare related investments. He is Founder/Managing Partner at GT Healthcare Partners, an innovative private equity operator focusing on cross border healthcare investments. Alan was senior adviser to Simcere Pharmaceutical Group, a leading pharmaceutical company in China (previously listed on NYSE:SCR, privatized in Dec 2013, when Alan was Chairman of the Special Committee on the Board of Directors). He was also a member of the Board, Audit Committee and Compensation Committee of China Nepstar Chain Drugstore Ltd. (NYSE: NPD, privatized in Sep 2016) from 2013 to 2016. Separately, Alan is a member of the Board, Audit Committee and Chairman of Nomination Committee of Cellular BioMedicine Group Inc. (Nasdaq: CBMG), a leader in immune-oncology in China. In addition, he has served as a panel member for the Entrepreneur Support Scheme (ESS Program) of the Innovation and Technology Fund of the Hong Kong SAR Government since 2014. Before that, Alan was Head of Asia Healthcare Investment Banking of Deutsche Bank Group, advising healthcare IPOs and M&A in the region between 2011 and 2012. Prior to that, he was Executive Director at JAFCO Asia Investment Group, responsible for healthcare investments in China from 2008 to 2010, and Investment Director at Morningside Group, managing healthcare investments in Asia from 2000 to 2005. From 1995 to 1999, Mr. Au worked at KPMG and KPMG Corporate Finance Ltd., taking care of regional M&A transactions and financial advisory services. Alan is a Certified Public Accountant in the U.S. and holds the Chartered Financial Analyst (CFA) designation. He is an associate member of the Hong Kong Institute of Financial Analysts and member of the American Institute of Certified Public Accountants. Alan received his Bachelor’s degree in Psychology from the Chinese University of Hong Kong, and a Master’s degree in Management from Columbia Business School in New York.
current job
Alan Au